Concepedia

Author

P S Gaynon

University of Chicago

Also Known As

P Gaynon, P S Gaynon, P. Gaynon, P. S. Gaynon, P.S. Gaynon, Paul S. Gaynon

21

Publications

1.1K

Citations

12

H-Index

23

Concepts

All Affiliations

University of ChicagoChildren's Oncology GroupMemorial Sloan Kettering Cancer CenterParker Hughes Cancer CenterCincinnati Children's Hospital Medical Center
PS

About

P S Gaynon is an author at University of Chicago specializing in health sciences, hematology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

4

4

172

2

Medicine

4

4

185

3

Gastroenterology

1

1

12

4

Hepatology

1

1

12

5

Immunology

1

1

117

P S Gaynon

×

11

Publications

967

Citations

11

H-Index

YearCitations

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

Peter G. Steinherz, P S Gaynon, John C. Breneman,

Journal of Clinical Oncology

1996

179

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.

Fatih M. Uckun, Martha G. Sensel, H N Sather,

Journal of Clinical Oncology

1998

145

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.

James B. Nachman, H N Sather, Joel M. Cherlow,

Journal of Clinical Oncology

1998

133

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.

James B. Nachman, H N Sather, P S Gaynon,

Journal of Clinical Oncology

1997

121

RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia

John P. Perentesis, Eleanor Boyle, Ying Shao,

Leukemia

2004

117

Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.

Fatih M. Uckun, P S Gaynon, Martha G. Sensel,

Journal of Clinical Oncology

1997

106

Young adults 16-21 years of age at diagnosis entered on childrens cancer group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment

James B. Nachman, Harland N. Sather, Jonathan D. Buckley,

Cancer

1993

87

Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.

Gregory H. Reaman, P. Steinherz, P S Gaynon,

PubMed

1987

32

No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities

Anthony V. Moorman, S Raimondi, C-H Pui,

Leukemia

2005

24

#672 Oral 6-thioguanine (TG) causes relatively mild and reversible hepatic venoocclusive disease (VOD)

Linda C. Stork, G. Erdmaru, Philip D Adamson,

Journal of Pediatric Hematology/Oncology

1998

12

Page 1